Top Story

Study results show no clear link between calcium channel blockers, breast cancer

December 19, 2014

CHICAGO — Analysis of a potential link between use of calcium channel blockers and risk for breast cancer yielded conflicting results in two separate cohorts, according to results presented at the American Heart Association Scientific Sessions.

Researchers conducted separate analyses of general patients (n=2,612) and patients who underwent coronary angiography (n=1,106) at Intermountain Healthcare facilities in Utah. All patients were female, aged 50 to 70 years and had no history of breast cancer.

CMS releases new quality of care data on physicians, ACOs, hospitals

December 19, 2014
CMS released new data on the quality of care provided by physician group practices, hospitals and Accountable Care Organizations, according to the CMS Blog.Included in…
Meeting News Coverage

BLAST: Blinatumomab may effectively combat minimal residual disease in ALL

December 19, 2014
SAN FRANCISCO — About 80% of patients with acute lymphoblastic leukemia experienced a minimal residual disease response after treatment with blinatumomab…
Meeting News Coverage

Benefit of anastrozole vs. tamoxifen varied by breast cancer subtype

December 18, 2014
SAN ANTONIO — The survival benefit postmenopausal patients with breast cancer derive from anastrozole vs. tamoxifen varies considerably by histology, according to…
In the Journals

Addition of monoclonal antibody to reduced-intensity conditioning regimen effective in advanced B-cell lymphoma

December 18, 2014
The addition of the CD20-directed monoclonal antibody 90Y-Ibritumomab tiuxetan to a reduced-intensity fludarabine-based conditioning regimen followed by allogeneic…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
IBIS-I: Tamoxifen provides long-term protection for women at high risk for breast cancer

IBIS-I: Tamoxifen provides long-term protection for women at high risk for breast cancer

December 12, 2014
SAN ANTONIO — Erin W. Hofstatter, MD, director of the Breast Cancer Genetics and Prevention Program at Yale…
More »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »